---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-020148"
form_type: "8-K"
ticker: "PLSH"
cik: "0001552189"
company_name: "PANACEA LIFE SCIENCES HOLDINGS, INC."
filed_at: "2022-07-22T23:59:59+00:00"
generated_at: "2026-06-24T09:33:27.416706+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Dr. Janice Nerger resigns from Panacea Life Sciences board effective July 21, 2022

## Summary
- Dr. Janice Nerger resigned from the board effective July 21, 2022, to accept interim provost role at Colorado State University.
- Resignation is effective immediately; no replacement or further details provided.
- Board size and remaining directors not disclosed in the filing.

## SEC filing metadata
- accession: 0001493152-22-020148
- form_type: 8-K
- ticker: PLSH
- cik: 0001552189
- company_name: PANACEA LIFE SCIENCES HOLDINGS, INC.
- filed_at: 2022-07-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1552189/000149315222020148/0001493152-22-020148-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1552189/000149315222020148/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-020148
- JSON: https://secwatch.observer/filing/0001493152-22-020148.json
- Plain text: https://secwatch.observer/filing/0001493152-22-020148.txt

## Key facts
- Executive change
  Janice Nerger resigned as Director at PANACEA LIFE SCIENCES HOLDINGS, INC..
  - Action: resigned
  - Role: Director
  source text: On July 21, 2022, Dr. Janice Nerger resigned as a member of the Board of Directors of Panacea Life Sciences Holdings, Inc., effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1552189/000149315222020148/0001493152-22-020148-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.